IFNA2

This article was updated by an external expert under a dual publication model. The corresponding peer-reviewed article was published in the journal Gene. Click to view.
Source: Wikipedia, the free encyclopedia.

IFNA2
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_000605

NM_010503

RefSeq (protein)

NP_000596

NP_034633

Location (UCSC)Chr 9: 21.38 – 21.39 MbChr 4: 88.6 – 88.6 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Interferon alpha-2 is a protein that in humans is encoded by the IFNA2 gene.[5]

Protein family

Human

epithelial cells
while type I IFNs act on all body's cells.

Type I IFNs form a family of several proteins: in humans, there are 13 α subtypes, 1 β subtype, 1 ω subtype and other less studied subtypes (κ and ε).[7] IFNα2 was the first subtype to be characterized in the early eighties. As a result, IFNα2 was widely used in basic research to elucidate biological activities, structure and mechanism of action of type I IFNs. IFNα2 was also the first IFN to be produced by the pharmaceutical industry for use as a drug. Thereby, IFNα2 is the best known type I IFN subtype. The properties of IFNα2 are widely shared by the other type I IFNs, although subtle differences exist.

Gene and protein

The

allelic variants, have been identified in the human population.[12] Among them, IFNα2a and IFNα2b are better known by their commercial name, Roferon-A and Intron A
, respectively. Upstream of the coding sequence is the
transcription of the IFNA2 gene into a messenger RNA (mRNA).[13][14] The amino acid sequences of IFNα2a and IFNα2b differ only at position 23 (lysine in IFNα2a, arginine in IFNα2b).[15]

Synthesis

When a cell is infected by a virus, some components of the virus, mainly viral

transcription factors
that translocate into the nucleus and activate the transcription of type I IFNs genes and thereby initiate the process leading to the secretion of IFN by the infected cells. The "danger" signals carried by viruses were the first IFN inducers described but it is now known that non-viral "danger" signals, such as some types of dead cells, can stimulate the synthesis of type I IFNs.

Mechanism of action

Induced IFNα2 is secreted by the infected cells and acts locally as well as systemically on cells expressing a specific

IFNAR) is composed of two subunits, IFNAR 1 and IFNAR 2, which are expressed by all body's cells. After binding to its receptor,[17] type I IFNs activate multiple cellular factors that transduce the signal from the cell surface into the nucleus.[18] The main signaling pathway activated by type I IFNs consists of a series of events:[19]

ISGs encode proteins that modulate cellular functions. Following viral infection, many ISGs lead to the inhibition of the viral spread.[16] Several ISGs inhibit viral replication in the infected cells. Other ISGs protect neighbouring uninfected cells from being infected by inhibiting viral entry. Several hundreds of ISGs are known to be activated by type I IFNs[20] and are listed in a searchable database named interferome (http://www.interferome.org/).

Function

The broad spectrum of ISGs explains the wide range of biological activity of type I IFNs.[16][21][22][23][24] In addition to their antiviral activity, type I IFNs also inhibit the proliferation of cells and regulate the activation of the immune system.

Type I IFNs exert potent antitumor activity by several mechanisms such as:

  • inhibition of the proliferation of cancer cells
  • activation of the immune system which can eliminate tumor cells[25][26]
  • increasing the antitumor activity of other antitumoral agents (
    targeted therapies)[27][28][29]

Type I IFNs can have detrimental effects during viral and non-viral infections (bacterial, parasitic, fungal). This is due in part by the ability of type I IFNs to polarize the immune system towards a specific type of response in order to interfere with virus infections.

When improperly regulated, IFN production or IFN-induced signalling can result in

autoimmune diseases, such as systemic lupus erythematosus.[30]

Clinical significance

If given orally, IFNα2 is degraded by

linked to IFNα2) are long-lasting IFNα2 formulations, which enable a single injection per week.

Recombinant IFNα2 (α2a and α2b) has demonstrated efficiency in the treatment of patients diagnosed with some viral infections (such as chronic viral

adverse effects.[33] Anecdotal evidence suggests interferon alfa 2b is effective antiviral treatment in COVID-19[34]

Notes

References

Further reading

External links

This page is based on the copyrighted Wikipedia article: IFNA2. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy